TY - JOUR
T1 - Cost-Effectiveness of Pembrolizumab in Combination with Platinum-Based Chemotherapy in First-Line for Squamous and Nonsquamous Non Small-Cell Lung Cancer. Far from Economic Sustainability
Y1 - 2021
PY - 2021
DA - 2021
N1 - doi:2021.96518
T2 - EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
JF - EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
JO - EJMO
SP - 59
EP - 62
VL - 5
IS - 1
SN - 
M3 - doi:2021.96518
UR - https://dx.doi.org/10.14744/ejmo.2021.96518
Y2 - 2021
ER -